Boston Scientific Corp (BSX.N)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|53||2016||Chairman of the Board, President, Chief Executive Officer|
|53||2014||Chief Financial Officer, Executive Vice President|
|45||2017||Executive Vice President and Global President - Interventional Cardiology|
|54||2014||Executive Vice President and President - Rhythm Management|
|55||2015||Executive Vice President - Operations|
- Boston Scientific trims 2019 sales growth forecast on weak first quarter, shares fall
- Boston Scientific sees $25 million hit to 2019 revenue from mesh withdrawal
- Boston Scientific sees $25 mln hit to 2019 revenue from mesh withdrawal
- UPDATE 3-U.S. FDA orders transvaginal surgical mesh pulled from market
- U.S. FDA orders withdrawal of transvaginal surgical mesh from market